MRNA is expected to report earnings to fall 9,166.67% to -272 cents per share on February 20
Q4'24
Est.
$-2.72
Q3'24
Beat
by $1.95
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.48
Q4'23
Beat
by $1.54
The last earnings report on November 07 showed earnings per share of 2 cents, beating the estimate of -191 cents. With 4.22M shares outstanding, the current market capitalization sits at 15.69B.